StonvexLoading…
StonvexStonvexStonvexCore line items from BILL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $1.46B | $1.29B | $1.06B | $641.96M |
Operating Income | $-80.60M | $-174.16M | $-295.77M | $-316.82M |
Net Income | $23.80M | $-28.88M | $-223.72M | $-326.36M |
EPS (Diluted) | $-0.07 | $-0.27 | $-2.11 | $-3.21 |
Total Assets | $10.06B | $9.18B | $9.64B | $9.26B |
Total Liabilities | $6.15B | $5.04B | $5.55B | $5.21B |
Cash & Equivalents | $1.04B | $985.94M | $1.62B | $1.60B |
Free Cash Flow OCF − CapEx | $346.31M | $277.80M | $180.18M | $-23.47M |
Shares Outstanding | 103.01M | 106.65M | 106.55M | 104.73M |